logo
logo
Sign in

Dental Membrane And Bone Graft Substitute Market Estimated to Witness High Growth Owing to Increase in Dental Implant Surgeries

avatar
Omkar Patel
Dental Membrane And Bone Graft Substitute Market Estimated to Witness High Growth Owing to Increase in Dental Implant Surgeries

Dental membrane and bone graft substitutes are clinically proven products used for various dental applications such as dental implants, ridge augmentation, sinus lifting and socket preservation. These products promote bone regeneration and reduce healing time for dental surgical procedures. Dental membranes act as a barrier to prevent soft tissue penetration and help manage guided bone regeneration. Bone grafts are used as scaffold to support new bone formation.

The global dental membrane and bone graft substitute market is estimated to be valued at US$ 1,045.3 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics: The dental membrane and bone graft substitute market is primarily driven by increasing number of dental implant surgeries worldwide. As per the International Team for Implantology, over 3.6 million dental implants are placed each year globally. Growing incidence of dental diseases, rising awareness regarding oral health care and increasing expenditure on dental healthcare are fueling the demand for dental implants. According to the American Academy of Implant Dentistry, nearly 10 million Americans are missing all their teeth in one or both jaws. Growing geriatric population which is more prone to dental diseases is facilitating the dental membrane and bone graft substitute market growth.

SWOT Analysis

Strength: Dental membrane and bone graft substitutes offer minimally invasive treatment options for bone and gum regeneration. They help avoid painful harvesting from other parts of the body. Some membranes and grafts are synthetically made to be biocompatible and promote natural healing without rejection risks. This enhances patient outcomes and recovery.

Weakness: The cost of certain premium dental membranes and bone grafts can be high for some patients and healthcare systems. Some traditional treatments like autografts from a patient's own body are still preferred by some clinicians despite potential drawbacks.

Opportunity: An aging global population experiences more oral health issues necessitating bone and tissue regeneration procedures. Growing awareness about benefits of substitutes over harvesting techniques can boost their demand. More affordable and advanced products through R&D further increase accessibility.

Threats: Stringent regulatory approvals for new materials delay their commercialization and availability to doctors and patients. Reimbursement policies also influence the affordability and adoption rates of certain premium products. Alternative treatment methods eating into market share is another threat.

Key Takeaways

The global dental membrane and bone graft substitute market is expected to witness high growth. The global dental membrane and bone graft substitute market is estimated to be valued at US$ 1,045.3 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030.

The regional analysis related content comprises North America dominates the global dental membrane and bone graft substitute market currently owing to supportive reimbursement scenarios and growing healthcare expenditure on dental procedures in the region. However, Asia Pacific market is anticipated to witness the highest CAGR during the forecast period with India, China and South Korea being the fastest growing regional markets. Increasing medical tourism, growing dental concerns among aging population coupled with rising awareness about various bone grafting procedures are some of the key factors expected to drive the APAC dental membrane and bone graft substitute market.

Key players operating in the dental membrane and bone graft substitute market are Dentsply Sirona, Johnson & Johnson, Geistlich Pharma, Zimmer Biomet, Institut Straumann AG., ACE Surgical Supply Company, BioHorizons, OraPharma, LifeNet Health, Dentium. Rising R&D investments by these companies in advanced biomaterials and technologies will expand product pipelines meeting more complex clinical needs. Partnerships with hospitals, dental clinics for training and awareness campaigns will strengthen market presence across regions.

collect
0
avatar
Omkar Patel
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more